We are live on
!
Find out more
ORIAW
Orion Biotech Opportunities Corp. Warrant
ORIAW
ORIAW
Delisted
ORIAW was delisted on the 28th of April, 2023.
29 hedge funds and large institutions have $1.85M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% less funds holding
Funds holding: 30 → 29 (-1)
29% less capital invested
Capital invested by funds: $2.63M → $1.85M (-$774K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
3
Calls
$544K
Puts
–
Net Calls
+$544K
Net Calls Change
-$13K
Top Buyers
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$8.29K |
| 2 |
CS
Clear Street
New York
|
+$1.84K |
Top Sellers
| 1 |
CAC
Cowen and Company
New York
|
-$10K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$710 |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
-$278 |
| 4 |
EAM
Empery Asset Management
New York
|
-$97 |